Name | Number of supported studies | Average coverage | |
---|---|---|---|
type II pneumocyte | 7 studies | 44% ± 14% | |
cardiac muscle cell | 6 studies | 53% ± 21% | |
mast cell | 6 studies | 25% ± 3% | |
endothelial cell of lymphatic vessel | 6 studies | 34% ± 12% | |
endothelial cell | 5 studies | 25% ± 10% | |
macrophage | 4 studies | 36% ± 15% | |
regulatory T cell | 3 studies | 21% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
heart | 4 studies | 28% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 357.94 | 327 / 328 | 6% | 0.08 | 10 / 178 |
muscle | 99% | 507.85 | 798 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 2902.57 | 855 / 861 | 0% | 0 | 0 / 0 |
adipose | 87% | 118.78 | 1047 / 1204 | 0% | 0 | 0 / 0 |
thymus | 81% | 95.02 | 530 / 653 | 2% | 0.03 | 10 / 605 |
blood vessel | 81% | 105.76 | 1086 / 1335 | 0% | 0 | 0 / 0 |
lung | 76% | 353.71 | 440 / 578 | 5% | 0.12 | 57 / 1155 |
spleen | 80% | 73.55 | 194 / 241 | 0% | 0 | 0 / 0 |
breast | 72% | 77.96 | 330 / 459 | 1% | 0.02 | 11 / 1118 |
adrenal gland | 68% | 72.03 | 176 / 258 | 3% | 0.07 | 6 / 230 |
bladder | 67% | 48.33 | 14 / 21 | 2% | 0.04 | 8 / 504 |
ovary | 59% | 51.22 | 107 / 180 | 0% | 0.00 | 1 / 430 |
lymph node | 0% | 0 | 0 / 0 | 59% | 1.69 | 17 / 29 |
esophagus | 54% | 49.05 | 776 / 1445 | 2% | 0.07 | 3 / 183 |
intestine | 53% | 42.38 | 514 / 966 | 2% | 0.05 | 11 / 527 |
uterus | 47% | 55.89 | 80 / 170 | 4% | 0.26 | 17 / 459 |
brain | 36% | 27.57 | 952 / 2642 | 9% | 0.15 | 62 / 705 |
stomach | 40% | 30.34 | 143 / 359 | 4% | 0.08 | 11 / 286 |
prostate | 24% | 17.25 | 58 / 245 | 16% | 0.56 | 78 / 502 |
peripheral blood | 34% | 91.10 | 317 / 929 | 0% | 0 | 0 / 0 |
skin | 22% | 13.12 | 397 / 1809 | 7% | 0.14 | 31 / 472 |
kidney | 15% | 9.02 | 13 / 89 | 6% | 0.12 | 52 / 901 |
liver | 13% | 7.09 | 29 / 226 | 1% | 0.04 | 5 / 406 |
eye | 0% | 0 | 0 / 0 | 1% | 0.01 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051642 | Biological process | centrosome localization |
GO_0021799 | Biological process | cerebral cortex radially oriented cell migration |
GO_0005813 | Cellular component | centrosome |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
Gene name | CCDC141 |
Protein name | Coiled-coil domain containing 141 CCDC141 protein Coiled-coil domain-containing protein 141 (Coiled-coil protein associated with myosin II and DISC1) |
Synonyms | hCG_22663 FLJ39502 CAMDI |
Description | FUNCTION: Plays a critical role in cortical radial and GnRH neurons migration during brain development. Regulates cortical radial migration by negatively controlling the activity of histone deacetylase 6 (HDAC6) and promotes centrosome maturation. CAMDI is required for dilation formation of cortical neurons during radial migration. Plays a critical role in learning and memory performance through regulation of AMPA-selective glutamate receptors (AMPARs) cell surface expression in competition with KIBRA. . |
Accessions | ENST00000343876.6 A0A0A6YYF7 ENST00000446116.5 Q2VPJ5 ENST00000443758.7 [Q6ZP82-2] ENST00000409284.1 C9JR62 B8ZZB3 Q6ZP82 |